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SUMMARY
The aim of the present study was to evaluate the oncological efficacy of salvage total laryngectomy in patients who had previously under-
gone supracricoid partial laryngectomy or transoral laser microsurgery for treatment of laryngeal squamous cell carcinoma. We retrospec-
tively reviewed the medical, surgical and pathological records of 35 patients who underwent salvage total laryngectomy after recurrence 
of laryngeal cancer (following supracricoid partial laryngectomy or transoral laser microsurgery). Kaplan-Meier survival curves as well as 
univariate and multivariate analyses of prognostic factors were performed. No statistically significant differences were seen comparing the 
supracricoid partial laryngectomy group with the transoral laser microsurgery group for overall survival and disease-specific survival at 3 
years (OS = 38% vs. 52%, p = 0.16; DSS = 40% vs. 61%, p = 0.057) or locoregional control at 2 years (LRC = 40% vs. 54%, p = 0.056). 
A trend indicating worse survival and locoregional control for supracricoid partial laryngectomy patients emerged. Preservation of the 
osteocartilaginous frame in transoral laser microsurgery could hypothetically result in better salvageability of anterior recurrences with 
extralaryngeal spread.
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RIASSUNTO
Lo scopo del presente studio è stato quello di valutare l’efficacia oncologica della laringectomia totale di salvataggio in pazienti prece-
dentemente sottoposti a laringectomia subtotale open o microchirurgia laser transorale affetti da carcinoma squamocellulare laringeo. 
Abbiamo analizzato retrospettivamente le informazioni cliniche, chirurgiche e patologiche di 35 pazienti sottoposti a laringectomia totale 
di salvataggio dopo recidiva di carcinoma laringeo (laringectomia subtotale open o transorale). Le informazioni sono state analizzate 
tramite l’utilizzo delle curve di Kaplan-Meier nonché tramite l’analisi univariata e multivariata dei fattori prognostici. Non sono emerse 
differenze statisticamente significative nel confronto tra il gruppo di pazienti precedentemente sottoposti a laringectomia subtotale ed il 
gruppo sottoposto a microchirurgia laser transorale sia in termini di overall survival (OS) e disease specific survival (DSS) a 3 anni (OS 
= 38% vs 52%, p = 0,16; DSS = 40% vs 61%, p = 0,057) che di controllo locoregionale (LRC) a 2 anni (LRC = 40% vs 54%, p = 0,056). 
È stata tuttavia messa in evidenza una tendenza che indica una sopravvivenza e controllo locoregionale peggiore nei pazienti sottoposti a 
laringectomia subtotale. La conservazione dello scheletro osteocartilagineo della microchirurgia laser transorale si traduce ipoteticamen-
te in una maggiore probabilità di salvataggio delle recidive anteriori con diffusione extralaringea.
PAROLE CHIAVE: Carcinoma • Laringe • Laringectomia totale di salvataggio • Laringectomia sopracricoidea • Microchirurgia laser 
transorale
Acta Otorhinolaryngol Ital 2016;36:373-380
Introduction
Supracricoid partial laryngectomy (SPL) and transoral 
laser microsurgery (TLM) are conservative surgical tech-
niques performed for treatment of laryngeal squamous 
cell carcinoma (LSCC) allowing for effective preserva-
tion of laryngeal function with excellent oncological re-
sults 1 2. 
SPL is an ‘open’ technique that involves the opening of 
the laryngeal box, removal of the thyroid cartilage, false 
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cords, true vocal cords, epiglottis (or part of it) and, when 
necessary, one arytenoid. At the end of the procedure, a 
pexy between the cricoid cartilage and the hyoid bone is 
performed  1 3. TLM is an endoscopic technique through 
which the LSSC is removed, generally without violating 
cartilage structures. The procedure does not involve the 
creation of communications between the laryngeal box 
and laterocervical spaces 2 4. SPL and TLM pose impor-
tant decisional problems in cases of suspected local recur-
rence with anterior extralaryngeal extension. 
In general, the anterior extralaryngeal spread of a re-
lapsing LSCC can occur in supraglottic primary (mainly 
through the thyrohyoid membrane) and glottic primary 
cases (through the thyrohyoid and cricothyroid mem-
branes or directly through the thyroid cartilage)  5  6. The 
latter rarely occurs. However, the potential for tumour ex-
tralaryngeal spread increases in anterior relapsing lesions 
previously treated with conservative surgical techniques, 
such as supracricoid partial laryngectomy (SPL) or tran-
soral laser microsurgery (TLM). In these cases, the com-
plete absence of the thyroid cartilage (in the case of SPL) 
or of the internal perichondrium (in the case of TLM) may 
facilitate anterior extralaryngeal spread 7.In the majority 
of cases it is possible to classify LSSC anterior relapse 
into 3 categories:
1. local recurrent tumour inside the neolarynx; 
2. extra-laryngeal only pattern: no tumour inside the neo-
larynx, fully extra-laryngeal recurrence; 
3. undetermined recurrence pattern.
The treatment of recurrent LSCC with suspected anterior 
extralaryngeal extension in the absence of direct invasion 
of vital structures is surgical. In most cases, an extended 
total laryngectomy is required that includes not only the 
removal of the larynx in its entirety, but also prelaryngeal 
muscles, thyroid gland, and when necessary, a portion of 
the overlying skin 8. The aim of the present study was to 
evaluate the oncological efficacy of salvage total laryn-
gectomy (STL) in recurrent LSCC with anterior extra-
laryngeal invasion in patients who had previously under-
gone to SPL or TLM. 
Materials and methods
We retrospectively reviewed the medical, surgical and 
pathological records of 43 patients who underwent STL 
between March 1990 and December 2014 at Policlinico 
Umberto I, ‘Sapienza’ University of Rome for LSCC with 
anterior extralaryngeal invasion (rcT4a) at first diagnosis 
or recurrence after conservative surgical treatment with 
SPL or TLS. Patient characteristics, including age, gender 
and KPS at diagnosis, were recorded.
Inclusion and exclusion criteria 
We identified 2 patient groups: patients primarily treated 
with SPL and those primarily treated with TLM. Patients 
who were ineligible for treatment with a radical intent 
and/or with known distant metastases, patients who did 
not undergo follow-up and those affected by non-squa-
mous histologies were excluded. Patients with an extra-
laryngeal spreading pattern without clinical evidence of 
intralaryngeal cancer were excluded as well. Based on in-
clusion and exclusion criteria, 35 patients were enrolled: 
16 patients underwent primary SPL before STL (Group 
1) and 19 underwent primary TLM before STL (Group 
2). The Institutional Review Board of the Policlinico Um-
berto I Hospital, Rome, Italy approved the study.
Treatment and indications. In the group of patients who 
were primarily treated with TLM, the main treatment was 
endoscopic laser cordectomy (i.e., type II, III, IV, or V) in 
glottic cases or endoscopic laser horizontal supraglottic 
laryngectomy associated with mono or bilateral neck dis-
section in the supraglottic cases (level II-IV + Delphian 
node in N0 cases; I-VI in N+ cases). In the group of pa-
tients who were primarily treated with SPL, the primary 
treatment was cricohyoidopexy or a cricohyoid-epiglot-
topexy associated with mono or bilateral neck dissection 
(level II-IV + Delphian node in N0 cases; I-VI in N+ cas-
es). Cricohyoidopexy was the preferred treatment in cases 
of anterior commissure involvement. All patients partici-
pating in the study underwent STL for anterior LSCC re-
currences with suspected extralaryngeal spread.
Salvage total laryngectomy (STL)
When cervical skin removal is planned (according to the 
clinical status of the tumour), the skin area that is to be 
removed is outlined. Immediately after the incision of the 
skin, frozen sections are obtained to determine whether 
the skin is affected by subcutaneous neoplastic lymphang-
itis. The incision is continued at full thickness without dis-
secting the cutaneous, subcutaneous, fascial and muscular 
planes overlying the laryngeal lodge. When skin removal 
was not considered, a subplatismal U-shaped cervical flap 
was elevated. The upper resection boundaries include 
the hyoid bone, whereas the lower margins may include, 
when necessary, the entire thyroid gland and two or more 
tracheal rings, depending on the subglottic extension of 
the tumour. Hypopharynx defects are restored as in con-
ventional total laryngectomy, whereas the anterior defect 
involving skin, fascia and muscle is restored using a pec-
toralis major myo-cutaneous flap. The lower margin of the 
myocutaneous flap is sutured to the upper rim of the first 
remaining tracheal ring. A wide stoma is then created.
Neck dissection and adjuvant treatment
The cN0 patients underwent elective selective neck dis-
section unless they had already been dissected in a previ-
ous surgery, with removal of levels II to IV, according to 
the main international guidelines. A comprehensive neck 
dissection was performed for clinically-positive nodal 
disease. Adjuvant radiotherapy was performed in pN0-N1 
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cases. Adjuvant chemoradiation was performed (consider-
ing the patient’s performance status) in high risk patients: 
extracapsular spread, positive margins, intravascular inva-
sion, perineural invasion, pN2-N3 patients.
Outcome analysis. The follow-up was calculated from the 
date of the STL. The endpoints included overall survival 
(OS), disease-specific survival (DSS) and loco-regional 
control (LRC). Statistical analysis was performed using 
SPSS for Windows version 15.0. Survival curves were 
plotted using the Kaplan–Meier method. Univariate and 
multivariate analyses were performed using the Cox pro-
portional hazards model. A survival comparison was per-
formed using a log-rank test, and p values < 0.05 were 
considered to be statistically significant.
Results
Age distribution was not significantly different between 
the two groups. Demographics and stage distribution are 
reported in Table I. When comparing staging (T and N 
for primary and recurrent LSCC) and subsites for primary 
LSCC, no significant differences were found between the 
groups. The median follow-up in our population was 31 
months; therefore, 3-year survival rates are given. The 
median age of the entire group was 63 years (range 36-74 
years). Among recurrences, the median time from prima-
ry treatment to first recurrence was 9 months for the SPL 
group and 13 months for the TLM group, with a mean of 
11.5 and 14 months, respectively (p = 0.12). 
A submucosal recurrent pattern was observed in 29 pa-
tients (83%, 12 SPL group, 17 TLM group), while an un-
determined spreading pattern was observed in 6 patients 
(17%, 4 SPL group and 2 TLM group, Table I). Median 
time from primary treatment to first recurrence was 8 
months in the submucosal recurrent pattern (29 patients) 
and 14 months for the undetermined recurrence pattern (6 
patients), with a mean of 7.83 and 14 months, respectively 
(p < 0.001).
A nasogastric feeding tube was placed before the STL in 
all cases. Early and late sequelae and functional results, 
as well as the requirement for further adjuvant treatment, 
are summarised in Table II. We were unable to administer 
the recommended adjuvant treatment for comorbidities or 
low compliance in the post-operative period for 2 patients 
who underwent STL after SPL and 3 patients who under-
went STL after TLM.
Pathologic stage. Pre-operative (STL) clinical staging 
was confirmed by histologic analysis in the majority of 
cases. In 3 cases, which were clinically classified as T4a, 
the pathologic staging changed to T3 (3 TLM groups). 
In 4 cases, which were clinically classified as N+, the 
pathologic staging changed to N0 (2 SPL groups, 2 TLS 
groups). The margins on the definitive specimen were 
positive in 3 cases (2 SPL groups, 1 TLM group, Table I). 
However, no significant differences emerged when com-
paring the two groups according to pathologic staging and 
margin status.
Survival analysis and loco-regional control. Calculated 
from the date of STL, overall OS in the entire group was 
Table I. Patient characteristics and treatment modalities.
Characteristic STL after SPL (16) STL after TLM (19)
Age
Median 64 59
Range 39-73 36-74
Sex N (%)    
Male 15 (94) 17 (89)
Female 1 (6) 2 (11)
Disease-free interval (months)
Median 9 13
Range 3-27 5-35
Site of primary N (%)    
Supraglottis 10 (63) 5 (26)
Glottis 6 (37) 14 (74)
pT stage N (%)    
T1 4 (25) 5 (26)
T2 12 (75) 14 (74)
T3 -  
T4a -  
pN stage N(%)    
N0 14 (87) 18 (95)
N1 2 (13) 1 (5)
N2A - -
N2B - -
rT stage (on the pathology specimen) N (%)
T3 - 3 (16)
T4a 16 (100) 16 (84)
rN stage (on the pathology specimen) N (%)
N0 8 (50) 12 (63)
N1 4 (25) 4 (21)
N2A 2 (13) 1 (5)
N2B 1 (6) 2 (11)
N2C 1 (6) -
Spreading pattern N (%)    
Submucosal 12 (75) 17 (89)
Undetermined 4 (25) 2 (11)
Skin removal N (%)    
Yes 8 (50) 7 (37)
No 8 (50) 12 (63
Skin involvement N (%)    
Positive 4 (50) 4 (57)
Negative 4 (50) 3 (43)
Resection margins after SL N (%)
Positive 2 (13) 1 (5)
Negative 14 (87) 18 (95)
STL: salvage total laryngectomy; SPL: supracricoid partial laryngectomy; TLM: tran-
soral laser microsurgery. pT: primary tumour T stage; pN: primary tumour N stage; rT: 
recurrent tumour T stage; rN: recurrent tumour N stage.
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45% at 3 years; the DSS was 51% at 3 years (Fig. 1 a-b). 
No significant differences emerged comparing SPL 
vs. TLM for OS and DSS. However, a trend showing a 
worse survival was seen in SPL cases (3-year OS = 38% 
vs. 52%, p = 0.16; HR, 1.84, 95% CI, 0.72-4.66; 3-year-
DSS = 40% vs. 61%, p = 0.057; HR, 2.57, 95% CI, 0.90-
7.34, Fig. 2 a-b). This trend was confirmed if we consider 
locoregional control (LRC) as the endpoint. In fact, the 
SPL group showed worse LRC than the TLM group 
(3-year LRC = 40% vs. 54%, p = 0.056; HR, 2.44, 95% 
CI, 0.91-6.53) (Fig. 3).
Comparing the SPL and TLM groups using Cox univari-
ate and multivariate regression analyses, we found no 
significant associations between clinical parameters (i.e., 
age, gender, time to first recurrence, cT, rT, nodal involve-
ment at diagnosis and at recurrence, primary site, primary 
treatment, and margin status after STL) with DSS rates 
(Table III). 
Discussion
STL is an aggressive surgical technique characterised by 
removing the larynx/neo-larynx in addition to prelaryn-
geal soft tissue, strap muscles and, when subcutaneous 
lymphangitis is suspected, a skin area overlying the lar-
ynx (wide field laryngectomy)  7-9. Because the surgical 
removal is large, the surgical defect must be filled. There-Fig. 1. Overall (a) and disease-specific (b) survival rates.
A
B
Table II. Early and late sequelae, adjuvant/salvage treatment and functional endopoints.
STL after SPL 
(N=16)
n (%)
STL after TLM 
(N=19)
n (%)
Early reconstructive procedures
Myocutaneous pectoralis major flap 15 (94) 15 (79)
Myofascial pectoralis major flap 1 (6) 4 (21)
Early sequelae (within 60 days) N 
Neck bleeding 3 (19) 2 (11)
Wound infection 1 (6) -
Salivary fistula 3 (19) 2 (11)
Dysphagia 5 (31) 4 (21)
Persistent pain 2 (13) -
Late sequelae (after 60 days) 
Pain 4 (25) 3 (16)
Neck fibrosis 6 (38) 5 (23)
Dysphagia 4 (25) 4 (21)
Further treatments for cancer
Adjuvant radiotherapy 3 (19) 3 (16)
Adjuvant radiochemotherapy 11 (69) 13 (68)
Feeding/nasogastric tube 
Median removal time in days (range) 14 (8-51) 15 (12-42)
Permanent (PEG) 4 (25) 4 (21)
STL: salvage total laryngectomy; SPL: supracricoid partial laryngectomy; TLM: transoral laser microsurgery.
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fore, in our centre, we prefer to use a pedicled myocuta-
neous or myofascial pectoralis major flap, which reliably 
provides an adequate amount of well-vascularised tissue 
and is particularly useful in patients who have previously 
undergone surgery and are candidates for adjuvant radio 
and/or chemotherapy 10. Furthermore, the pectoralis major 
flap has been demonstrated by several reports to signifi-
cantly reduce local complications such as salivary fistu-
la 11. In our study, the pectoralis major flap was used for 
reconstruction purposes in all cases.
In this study, we investigated the results of STL in LSCC 
recurrences after SPL or TLM. To our knowledge, no 
similar studies evaluating a large series of STL have been 
previously published in the international literature. OS 
and DSS, post-operative morbidity, and mortality appear 
to be acceptable, especially considering the fact that we 
included only recurrent cases that by definition are char-
acterised by poor survival 12. 
We divided patients into two groups according to the pri-
mary tumour treatment: SPL or TLM. This allowed com-
parison of oncological data for salvage surgery following 
widely differing surgical techniques. Indeed, SPL is an 
‘open’ procedure that involves the opening of the laryn-
geal box, removal of the thyroid cartilage, false cords, true 
vocal cords, epiglottis (or part of it) and, when necessary, 
one arytenoid. Furthermore, a pexy between the cricoid 
cartilage and the hyoid bone is performed 1 3. TLM is an 
endoscopic technique that does not violate the laryngeal 
osteocartilaginous frame and the procedure does not in-
volve communications between the laryngeal box and 
laterocervical spaces 2 4. In our opinion, the main advan-
tage of SPL is the oncological radicality in LSCC with 
suspected or minimal cartilage invasion 13. Indeed, the on-
cological radicality of SPL in selected locally advanced 
LSCC is increasingly being confirmed in the recent litera-
ture 13-15. The main advantage of TLM seems to be linked 
to the possibility of treating LSCC without excluding fur-
ther therapeutic options in cases of new recurrences 2 16 17. 
Furthermore TLM is repeatable in the case of local early 
recurrence 18. 
Comparing the two groups according to OS and DSS, 
some trends were evident: SPL cases showed worse sur-
vival (OS = 38% vs. 52%, DSS = 40% vs. 61%), but there 
were no statistically significant differences (p = 0.16 and 
0.057, respectively). This trend was also confirmed when 
Fig. 2. Comparison between salvage wide field laryngectomy after supracricoid partial laryngectomy group (SPL) and salvage wide 
field laryngectomy after transoral laser microsurgery group (TLM) for overall (A) and disease-specific (B) survival.
Fig. 3. Comparison between salvage wide field laryngectomy 
after supracricoid partial laryngectomy group (SPL) and salva-
ge wide field laryngectomy after transoral laser microsurgery 
group (TLM) for locoregional control. 
A B
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we compared the two groups according to LRC: SPL was 
related to worse LRC (40% vs. 54%), albeit non-signifi-
cantly (p = 0.056). Furthermore, comparing the SPL and 
TLM groups using Cox univariate and multivariate re-
gression analyses, we found no significant correlations of 
clinical parameters with DSS rates (Table III). Although 
no significant differences emerged, we cannot exclude 
the possibility that a larger series would have obtained 
more representative data, which may have yielded statisti-
cally significant differences for OS, DSS and LRC. Note 
that LSCC cases with anterior extralaryngeal extension 
and candidates for surgery are rare and, in the literature, 
there are few data concerning the surgical treatment of 
this peculiar LSCC. Moreover, we should consider that, 
although extralaryngeal extension was radiologically 
strongly suspected in all cases, final pathological staging 
in TLM group was T3 in 3 cases (16%), while the SPL 
group included only T4a. Although the difference in stag-
ing was not significant, this could represent a potential 
bias.
The different clinical behaviours observed in the two 
groups and the better salvageability of TLM can be ex-
plained by the characteristics of the primary operation. In 
recurrences after SPL, the complete absence of thyroid 
cartilage allows the tumour to spread more directly, faster 
and (potentially) with no clinical manifestation in the an-
terior regions of the neck in the absence of a mechani-
cal barrier until extensive anterior involvement occurs. 
Table III. Univariate and multivariate analysis of prognostic covariates for DSS (calculated from the time of salvage).
Characteristic Univariate Analysis Multivariate Analysis
  HRa 95% CIb p HRa 95% CIb p
Age
Over 65 years 1 1
≤65 years 1.6 0.54 to 4.65 0.39 5.37 0.87 to 33,23 0.07
Sex
Female 1 1
Male 1.51 0.34 to 6.68 0.59 3.76 0.38 to 37.28 0.25
Time to first recurrence
Before 10 months 1 1
After 10 months 1.14 0.40 to 3.19 0.8 1.58 0.48 to 5.14 0.44
cT
cT1 1 1
cT2 1.39 0.39 to 4.88 0.61 5.12 0.61 to 42.88 0.13
rT
rT3 1 1
rT4a 2 0.26 to 15.14 0.5 0.25 0.01 to 5.25 0.37
Nodal involvement at first diagnosis
No 1 1
Yes 0.65 0.08 to 4.87 0.67 0.51 0.04 to 5.60 0.59
Nodal involvement at recurrence
No 1 1
Yes 1.45 0.80 to 2.61 0.22 1.96 0.81 to 4.74 0.13
Primary site
Glottis 1 1
Supraglottis 2.43 0.86 to 6.88 0.09 0.88 0.23 to 3.28 0.85
Primary Treatment
Supracricoid laryngectomy 1 1
Transoral laser microsurgery 0.383 0.13 to 1.07 0.07 0.23 0.05 to 1.08 0.06
Skin involvement
positive 1 1
negative 2.43 0.83 to 7.14 0.10 3.56 0.65 to 19.26 0.14
Salvage resection margins
Negative 1 1
Positive 1.92 0.42 to 8.64 0.4 5.92 0.71 to 49.39 0.1
a Hazard ratio; b Confidence interval.
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Conversely, TLM offers the great advantage of leaving 
the osteocartilaginous laryngeal frame, a valuable tumour 
spread barrier, largely intact (albeit by resecting the in-
ternal perichondrium). Preservation of the osteocarti-
laginous frame is the main factor underlying the better 
salvageability of recurrences as well as the better toler-
ance to adjuvant radiotherapy observed in cases treated 
endoscopically; this treatment triggered the progressive 
replacement of traditional open operations with endo-
scopic laser homologues, such as cordectomy, and (later) 
horizontal supraglottic laryngectomy 18 19. Therefore, the 
present results indirectly confirm the advantages of TLM 
in terms of recurrence salvageability.
In our opinion, the above delineated salvageability issues 
associated with primary SPL should not prevent the use 
of SPL. In fact, although there are conflicting data on the 
oncologic efficacy of TLM in the treatment of locally ad-
vanced LSCC, there is increasing evidence supporting the 
use of SPL in the primary treatment of advanced LSCC 
and as salvage treatment in early recurrent LSCC after 
radiotherapy with high organ preservation rates and sur-
vival 13 15 20-23. 
Finally, in the majority of cases it is possible to classify 
LSSC anterior relapse into three categories: 1) local recur-
rent tumour inside the neolarynx (visible as submucosal 
recurrence) in continuity with extralaryngeal spread; 2) 
extra-laryngeal only pattern: no tumour inside the neo-
larynx, fully extra-laryngeal recurrence. This is probably 
a regional recurrence due to ECS from Delphian lymph 
node or level VI nodes; 3) undetermined recurrence pat-
tern: tumour involving and destroying the remnant laryn-
geal framework with extralaryngeal extension. This is 
probably related to vascular or lymphatic permeation. We 
did not include extra-laryngeal only pattern in our study 
since in our opinion it could not be considered as a pure 
laryngeal relapse.
We observed that median time from primary treatment to 
first recurrence was 8 months in the submucosal recurrent 
pattern (29 patients, 83%) and 14 months for the undeter-
mined recurrence pattern (6 patients, 17%), with a mean 
of 7.83 and 14 months, respectively (p < 0.001). This re-
sult should be strongly emphasised since endoscopic ear-
ly detection of LSCC relapse with undetermined pattern is 
very difficult and, in our opinion, a higher level of caution 
in the follow-up is recommended after salvage laryngec-
tomy in SPL patients.
Globally, our results suggest that longer follow-up peri-
ods with stricter intervals (2 months for the first 2 years) 
using different imaging techniques (MRI and PET scan) 
can be useful in early detection of relapse. Moreover, the 
routine use of adjuvant chemoradiation (in case of favour-
able performance status) after STL should be considered 
in all cases to improve survival. Finally, further research 
is warranted to confirm our findings and to validate our 
speculations. 
Conclusions
To the best of our knowledge, the present study is the first 
to investigate the salvageability of recurrent LSCC with 
anterior suspected extralaryngeal extension after SPL or 
TLM. Although our results did not reach statistical sig-
nificance, there was a trend indicating lower survival and 
locoregional control in patients who had undergone STL 
for LSCC recurrence after SPL. This was probably due to 
the complete absence of thyroid cartilage in SPL patients. 
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